Intravenous Cannulation In Children During Sevoflurane Induction

August 17, 2017 updated by: Leila mansali stambouli

Intravenous Cannulation In Children During Sevoflurane Induction: Which Time is Adequate

This interventional simple-blind,randomized trial has included 90 children of American Society of Anesthesiologist (ASA) physical status I or II aged between 1 to 12 years of either sex, scheduled for for outpatient minor surgery under general anesthesia. This study examined whether one should make iv attempts during the early induction period (at 60 seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia.

Study Overview

Detailed Description

We conducted a prospective randomized study, after obtaining Institutional review board approval, which didn't require written parental consent. Children age 1-12 years, undergoing elective general anesthesia via an inhalation induction were randomized to one of three groups of 30 patients each one, for iv placement, either 60s (group E), 90 or 120 s (group L) following loss of lid reflex. Movement on iv placement and incidence of laryngospasm were determined. Difficulty with iv placement was also recorded. Statistical analysis included contingency testing, ANOVA, and non parametric testing. A P-value <0.05 was considered significant.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 12 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • children with American Society of Anesthesiologist (ASA) physical status I or II
  • age between 1 and 12 years of either sex,
  • were scheduled for outpatient minor surgery under general anesthesia

Exclusion Criteria:

  • age <1 and >12 years
  • patients with full stomach
  • a history of gastric reflux
  • history of convulsions, cardiovascular or neuromuscular disease
  • suspected difficult airway and hyper-reactive airway disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: 60s (group E)
The Time of catheterization at 60s (group E) was applied in this study group,after sevoflurane inhalation induction, 30 children have a catheterization after a time of 60 seconds following the eye closure and the loss of lid reflex.Difficulty with intravenous catheterization, limb movement and laryngospasm were recorded.Difficulty of catheterization in group 60 s
Other: 90s (groupe L)
In this study group,after sevoflurane inhalation induction, 30 children have a catheterization after a time of 90 seconds following the eye closure and the loss of lid reflex.Difficulty with intravenous catheterization, limb movement and laryngospasm were recorded.Difficulty of catheterization in group 90 s
Other: 120s (groupe L)
In this study group,after sevoflurane inhalation induction, 30 children have a catheterization after a time of 120 seconds following the eye closure and the loss of lid reflex.Difficulty with intravenous catheterization, limb movement and laryngospasm were recorded.Difficulty of catheterization in group 120 s

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Success of intravenous insertion
Time Frame: from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds
success insertion of intravenous cannula was achieved at the first attempt less than 30 seconds
from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
limb movement
Time Frame: from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds

The movement was classified using the scale:

(0 No movement, 1 movement) The incidence of laryngospasm was defined as the sudden complete or partial loss of air exchange with concurrent loss of a capnographic wave.

The movement was classified using the scale:

(0 No movement, 1 movement) The incidence of laryngospasm was defined as the sudden complete or partial loss of air exchange with concurrent loss of a capnographic wave.

• The movement was classified using the scale: (0 No movement, 1 movement)

• The movement was classified using the scale: (0 No movement, 1 movement) The limb movement was classified using the scale:0 No movement, 1 movement)

from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
laryngospasm
Time Frame: from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds
laryngospasm was defined as the sudden complete or partial loss of air exchange with concurrent loss of a capnographic wave.
from the end of study period of time after the loss of eyelash reflex to successful cannulation less than 30 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: leila Mansali Stambouli, MD PhD, University Hospital of Fattouma Bourguiba Monastir TUNISIA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

October 31, 2016

Study Completion (Actual)

October 31, 2016

Study Registration Dates

First Submitted

August 11, 2017

First Submitted That Met QC Criteria

August 17, 2017

First Posted (Actual)

August 18, 2017

Study Record Updates

Last Update Posted (Actual)

August 18, 2017

Last Update Submitted That Met QC Criteria

August 17, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • OMB: 0925-0586

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Catheterization

Clinical Trials on Difficulty of catheterization in group 60 s

3
Subscribe